Table 4 Problems managed – significant differences between groups in rates of management of problems in terms of ICPC-2 chapters & common problems managed.
Common chapters and individual problems | Unadjusted descriptive | Age-sex standardised | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Heavy drinkers (6+ at least weekly) | Â | Non-heavy drinkers | Heavy drinkers (6+ at least weekly) | Â | Non-heavy drinkers | ||||
| Â | Rate per 100 encounters (n = 5,753)(a) | 95% CI | Â | Rate per 100 encounters (n = 73,221)(a) | 95% CI | Rate per 100 encounters (n = 5,756)(a) | 95% CI | Â | Rate per 100 encounters (n = 73,152)(a) | 95% CI |
Psychological | 20.3 | 18.8–21.9 | ↑ | 12.7 | 12.3–13.2 | 22.1 | 19.8–24.5 | ↑ | 12.8 | 12.3–13.3 |
Depression* | 5.6 | 5.0–6.2 | ↑ | 4.5 | 4.3–4.7 | 6.7 | 5.5–7.9 | ↑ | 4.5 | 4.3–4.7 |
Chronic alcohol abuse | 3.2 | 2.6–3.8 | ↑ | 0.1 | 0.1–0.1 | 2.9 | 2.2–3.5 | ↑ | 0.1 | 0.1–0.1 |
Acute alcohol abuse | 1.7 | 1.4–1.7 | ↑ | <0.1 | 0.0–0.1 | 1.8 | 1.2–2.3 | ↑ | <0.1 | 0.0–0.1 |
Drug abuse | 1.2 | 0.9–1.6 | ↑ | 0.5 | 0.4–0.6 | 0.9 | 0.6–1.2 | -- | 0.6 | 0.4–0.7 |
Tobacco abuse | 1.0 | 0.8–1.5 | ↑ | 0.4 | 0.4–0.5 | 1.1 | 0.7–1.5 | ↑ | 0.4 | 0.4–0.5 |
Musculoskeletal | 20.7 | 19.4–22.0 | -- | 19.4 | 18.9–19.9 | 21.0 | 18.4–23.7 | -- | 19.4 | 18.9–19.9 |
Back complaint* | 4.2 | 3.6–4.7 | ↑ | 3.1 | 2.9–3.3 | 3.1 | 2.5–3.7 | -- | 3.2 | 3.0–3.4 |
Osteoarthritis* | 2.0 | 1.7–2.4 | ↓ | 3.1 | 3.0–3.3 | 3.8 | 2.5–5.1 | -- | 3.0 | 2.8–3.1 |
Fracture* | 1.9 | 1.5–2.3 | ↑ | 0.9 | 0.8–0.9 | 1.8 | 1.0–2.7 | -- | 0.9 | 0.8–1.0 |
Sprain/strain* | 2.7 | 2.3–3.2 | ↑ | 1.6 | 1.5–1.8 | 1.8 | 1.4–2.1 | -- | 1.7 | 1.6–1.9 |
Circulatory | 14.0 | 13.0–15.0 | ↓ | 19.7 | 19.1–20.2 | 17.7 | 15.3–20.0 | -- | 18.9 | 18.3–19.4 |
Hypertension* | 8.5 | 7.7–9.3 | ↓ | 10.9 | 10.5–11.2 | 11.3 | 9.4–13.1 | -- | 10.5 | 10.1–10.8 |
Ischaemic heart disease* | 1.0 | 0.7–1.3 | -- | 1.5 | 1.3–1.6 | 0.9 | 0.6–1.2 | ↓ | 1.4 | 1.3–1.5 |
Skin | 20.2 | 18.8–21.5 | ↑ | 16.1 | 15.6–16.6 | 16.9 | 15.1–18.7 | -- | 16.1 | 15.6–16.6 |
Laceration/cut | 1.2 | 0.9–1.5 | ↑ | 0.6 | 0.5–0.7 | 0.7 | 0.5–0.9 | -- | 0.6 | 0.6–0.7 |
Other skin symtpom/complaint | 1.1 | 0.8–1.4 | ↑ | 0.5 | 0.5–0.6 | 1.0 | 0.4–1.6 | -- | 0.6 | 0.5–0.6 |
Respiratory | 16.1 | 15.0–17.2 | ↓ | 18.6 | 18.1–19.2 | 15.9 | 14.2–17.7 | ↓ | 18.8 | 18.2–19.3 |
Endocrine & metabolic | 10.9 | 9.9–11.8 | ↓ | 12.6 | 12.2–13.0 | 12.2 | 10.5–13.9 | -- | 12.5 | 12.1–12.9 |
Diabetes* | 2.1 | 1.7–2.5 | ↓ | 3.6 | 3.5–3.8 | 2.6 | 1.7–3.4 | ↓ | 3.6 | 3.4–3.8 |
Gout | 1.5 | 1.2–12.8 | ↑ | 0.5 | 0.5–0.6 | 1.3 | 0.8–1.8 | ↑ | 0.5 | 0.5–0.6 |
Female Genital system | 4.2 | 3.6–4.8 | ↓ | 8.4 | 8.0–8.8 | 8.0 | 6.7–9.2 | -- | 8.8 | 8.4–9.2 |
Neurological | 3.4 | 2.7–4.1 | ↓ | 4.3 | 4.2–4.5 | 4.0 | 2.9–5.0 | -- | 4.3 | 4.2–4.5 |
Pregnancy and family planning | 3.2 | 2.5–3.9 | ↓ | 5.1 | 4.8–5.3 | 4.6 | 3.6–5.5 | -- | 5.2 | 4.9–5.5 |
Urological | 1.9 | 1.5–2.2 | ↓ | 3.2 | 3.0–3.3 | 2.8 | 1.8–3.9 | -- | 3.3 | 3.2–3.4 |
Digestive | 11.5 | 10.6–12.3 | ↑ | 10.1 | 9.7–10.3 | 11.7 | 10.2–13.3 | -- | 10.0 | 9.7–10.3 |